Table 2: Plasma levels of ASP and other parameters in 22 healthy controls and 25 patients with type 2 diabetes

		Healthy controls	Diabetes patients
Number of Samples	[n]	22	25
Age	[years old]	63±17	68±11
Body Mass Index (BMI)	[kg/m²]	24.6±5.7	25.9±4.2
Hemoglobin A1c (NGSP^b)	[%]	5.2±0.7	6.6±0.8^a
Immuno Reactive Insulin	[μU/mL]	9.2±6.4	15.7±13.1
HOMA-IR^c		2.7±1.0	6.5±7.4^a
Adiponectin (ADN)	[μg/mL]	8.7±1.8	4.1±3.6^a
Tumor necrosis factor α (TNF α)	[pg/mL]	0.9±0.8	3.1±5.9^a
C3	[mg/dL]	92±22	121±37^a
ic3b	[μg/mL]	65±27	306±21^a
Acylation stimulating protein (ASP)	[μg/mL]	169±22	224±36^a
Soluble membrane attack complex (sMAC)	[ng/mL]	2.13±0.72	3.43±0.70^a
Serum creatinine	[mg/dL]	0.68±0.15	1.41±0.14^a
Albumin creatinine ratio (ACR)	[mg/gCr]	18±9	695±180^a
eGFR^d	[mL/min]	78±32	50±25^a

Values are expressed as mean±SD, ^a: statistically significant vs. healthy controls, ^b: National glycohemoglobin standardization program, ^c: homeostasis model assessment of insulin resistance, ^d: eGFR: estimated glomerular filtration rate.